NYSE:HQL
Tekla Life Sciences Investors Stock News
$14.05
+0.160 (+1.15%)
At Close: May 14, 2024
Oculis Raises CHF15.5M in Extension of Series B Financing | FinSMEs
12:22pm, Friday, 04'th Jan 2019
Oculis, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments, raised a further CHF15.5m in Series B financing
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
12:00am, Monday, 17'th Dec 2018Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018
12:00am, Monday, 10'th Dec 2018Tekla Life Sciences Investors: A High Quality Biotech Fund To Generate Solid Returns
12:00am, Monday, 26'th Nov 2018Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
12:00am, Wednesday, 21'st Nov 2018Milestone Pharmaceuticals Raises $80M in Equity Funding | FinSMEs
04:08pm, Thursday, 25'th Oct 2018
Milestone Pharmaceuticals, a Montreal, Canada-based late-stage biopharma company developing interventions for tachycardias, completed an $80m financing
